EU drug regulator gives green light to Pfizer COVID pill for high-risk patients - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 51%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

The European Union’s drug regulator on Thursday gave the green light to Pfizer Inc’s antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the Omicron variant.

These oral drugs, especially Pfizer's, are seen as promising new treatment options that can be taken at home at the onset of COVID-19 symptoms to help prevent hospitalisations and deaths.

Italy, Germany and Belgium are among a handful of EU countries that have bought the drug, branded as Paxlovid.EU health commissioner Stella Kyriakides said the bloc was now making good progress on lining up treatments, which she described as a second line of defence after vaccines.

 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

And when it mutates again do tou need another?

When will be the final injection?

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 37. in EG

مصر أحدث الأخبار, مصر عناوين